Daphnia pulicaria isolate SC F1-1A chromosome 12, SC_F0-13Bv2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Branchiopoda; Diplostraca; Cladocera; Anomopoda; Daphniidae; Daphnia.
The roles of recombination and selection in shaping genomic divergence in an incipient ecological species complex
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM038035.1.\nAssembly name: SC_F0-13Bv2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Oklahoma on\n2022/01/11. The original whole-genome shotgun project has the\naccession JAJAGA000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Oklahoma\nAssembly Date :: 2020\nAssembly Method :: hifiasm v. 1; LepAnchor v. 1\nAssembly Name :: SC_F0-13B\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60x\nSequencing Technology :: PacBio Sequel; Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Daphnia pulicaria Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
pleckstrin homology domain-containing family G member 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pleckstrin homology domain-containing family G member 1-like
uncharacterized LOC124316105, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124316105, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124316769, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC124316769, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC124316770, transcript variant X1
uncharacterized LOC124316770, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
serine/threonine-protein kinase/endoribonuclease ire-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC124316111, transcript variant X3
uncharacterized LOC124316111, transcript variant X2
uncharacterized LOC124316111, transcript variant X1
complement C1q tumor necrosis factor-related protein 3-like
hemoglobin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hemoglobin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hemoglobin-1-like, transcript variant X3
ribosome production factor 2 homolog, transcript variant X2
ribosome production factor 2 homolog isoform X2
hemoglobin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hemoglobin-1-like, transcript variant X4
ribosome production factor 2 homolog, transcript variant X1
ribosome production factor 2 homolog isoform X1
spermatogenesis-associated protein 5-like protein 1
protein O-mannosyl-transferase TMTC4-like
ras-related and estrogen-regulated growth inhibitor-like protein
nuclear cap-binding protein subunit 2-like
uncharacterized LOC124316392, transcript variant X1
uncharacterized LOC124316392, transcript variant X2
vascular endothelial growth factor receptor kdr-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lactosylceramide 4-alpha-galactosyltransferase-like
protein Pixie-like, transcript variant X2
protein Pixie-like, transcript variant X1
guanine nucleotide exchange factor for Rab-3A-like
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X5
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X4
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X3
LON peptidase N-terminal domain and RING finger protein 3-like isoform X3
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X2
LON peptidase N-terminal domain and RING finger protein 3-like isoform X1
LON peptidase N-terminal domain and RING finger protein 3-like isoform X2
adenosine 5'-monophosphoramidase HINT1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
F-box/WD repeat-containing protein 1A-like
arrestin domain-containing protein 17-like
3-hydroxyanthranilate 3,4-dioxygenase-like
uncharacterized LOC124316624, transcript variant X2
uncharacterized LOC124316624, transcript variant X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2-like, transcript variant X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2-like, transcript variant X2
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2-like isoform X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase C-like isoform X2
alpha-(1,3)-fucosyltransferase C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase C-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
vascular endothelial growth factor receptor 3-like
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X2
lactosylceramide 4-alpha-galactosyltransferase-like isoform X2
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X5
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X4
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X3
lactosylceramide 4-alpha-galactosyltransferase-like isoform X3
vascular endothelial growth factor receptor 1-like, transcript variant X2
vascular endothelial growth factor receptor 1-like, transcript variant X1
vascular endothelial growth factor receptor 1-like isoform X2
vascular endothelial growth factor receptor 1-like isoform X1
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X6
vascular endothelial growth factor receptor 1-like
lactosylceramide 4-alpha-galactosyltransferase-like, transcript variant X7
eukaryotic translation initiation factor 2-alpha kinase-like
uncharacterized LOC124316655, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316655, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124316613, transcript variant X3
uncharacterized LOC124316613, transcript variant X1
uncharacterized LOC124316613, transcript variant X2
uncharacterized LOC124316171, transcript variant X2
uncharacterized LOC124316171, transcript variant X1
uncharacterized protein LOC124316171 isoform X2
uncharacterized protein LOC124316171 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial import inner membrane translocase subunit Tim8-like, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim8-like, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim8-like
clathrin light chain-like, transcript variant X2
clathrin light chain-like, transcript variant X1
mitochondrial coenzyme A diphosphatase NUDT8-like
uncharacterized LOC124316363, transcript variant X1
uncharacterized LOC124316363, transcript variant X2
serine/threonine-protein kinase tricornered-like, transcript variant X3
serine/threonine-protein kinase tricornered-like, transcript variant X2
serine/threonine-protein kinase tricornered-like, transcript variant X1
serine/threonine-protein kinase tricornered-like, transcript variant X4
serine/threonine-protein kinase tricornered-like
platelet-derived growth factor receptor alpha-like
kunitz-type serine protease inhibitor textilinin-3-like, transcript variant X1
kunitz-type serine protease inhibitor textilinin-3-like, transcript variant X2
kunitz-type serine protease inhibitor textilinin-3-like
opioid-binding protein/cell adhesion molecule homolog
Golgi-associated plant pathogenesis-related protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 4B-like, transcript variant X3
eukaryotic translation initiation factor 4B-like, transcript variant X2
eukaryotic translation initiation factor 4B-like, transcript variant X1
eukaryotic translation initiation factor 4B-like isoform X3
eukaryotic translation initiation factor 4B-like isoform X2
eukaryotic translation initiation factor 4B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
octopamine receptor beta-2R-like, transcript variant X2
octopamine receptor beta-2R-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC124316638, transcript variant X2
uncharacterized LOC124316638, transcript variant X4
uncharacterized LOC124316638, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124316638, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC124316630, transcript variant X2
uncharacterized LOC124316630, transcript variant X5
uncharacterized LOC124316630, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC124316630, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC124316630, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1-like
ankyrin repeat domain-containing protein 27-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 11-like
protein phosphatase 1 regulatory subunit 16A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
vascular endothelial growth factor receptor 3-like isoform X1
complement C1q tumor necrosis factor-related protein 3-like, transcript variant X1
complement C1q tumor necrosis factor-related protein 3-like, transcript variant X3
complement C1q tumor necrosis factor-related protein 3-like, transcript variant X2
uncharacterized protein LOC124316478 isoform X1
complement C1q tumor necrosis factor-related protein 3-like isoform X2
platelet-derived growth factor receptor alpha-like, transcript variant X3
platelet-derived growth factor receptor alpha-like, transcript variant X2
platelet-derived growth factor receptor alpha-like, transcript variant X1
platelet-derived growth factor receptor alpha-like isoform X3
vascular endothelial growth factor receptor 1-like, transcript variant X3
vascular endothelial growth factor receptor 1-like, transcript variant X5
vascular endothelial growth factor receptor 1-like, transcript variant X4
vascular endothelial growth factor receptor 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
quinone oxidoreductase-like, transcript variant X1
quinone oxidoreductase-like, transcript variant X2
uncharacterized LOC124316452, transcript variant X1
uncharacterized LOC124316452, transcript variant X2
uncharacterized protein LOC124316452 isoform X1
uncharacterized protein LOC124316452 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trypsin Blo t 3-like, transcript variant X1
trypsin Blo t 3-like, transcript variant X2
trypsin alpha-3-like, transcript variant X5
trypsin alpha-3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
trypsin alpha-3-like, transcript variant X2
trypsin alpha-3-like, transcript variant X3
trypsin alpha-3-like, transcript variant X7
trypsin alpha-3-like, transcript variant X9
trypsin alpha-3-like, transcript variant X1
trypsin alpha-3-like, transcript variant X6
trypsin alpha-3-like, transcript variant X8
AH receptor-interacting protein-like, transcript variant X2
AH receptor-interacting protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC124316618, transcript variant X2
uncharacterized LOC124316618, transcript variant X5
uncharacterized LOC124316618, transcript variant X4
uncharacterized LOC124316618, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124316618, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC124316554, transcript variant X3
uncharacterized LOC124316554, transcript variant X2
uncharacterized LOC124316554, transcript variant X1
uncharacterized LOC124316424, transcript variant X2
uncharacterized LOC124316424, transcript variant X3
uncharacterized LOC124316424, transcript variant X1
uncharacterized LOC124316425, transcript variant X3
uncharacterized LOC124316425, transcript variant X1
uncharacterized LOC124316425, transcript variant X2
uncharacterized LOC124316425, transcript variant X4
uncharacterized protein LOC124316425 isoform X1
uncharacterized protein LOC124316425 isoform X2
uncharacterized LOC124316454, transcript variant X7
uncharacterized LOC124316454, transcript variant X8
uncharacterized LOC124316454, transcript variant X4
uncharacterized LOC124316454, transcript variant X2
uncharacterized LOC124316454, transcript variant X1
uncharacterized LOC124316454, transcript variant X6
uncharacterized LOC124316454, transcript variant X5
uncharacterized LOC124316454, transcript variant X3
uncharacterized protein LOC124316454 isoform X3
uncharacterized protein LOC124316454 isoform X1
uncharacterized protein LOC124316454 isoform X2
uncharacterized LOC124316552, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124316552, transcript variant X1
uncharacterized protein LOC124316552 isoform X1
uncharacterized protein LOC124316552 isoform X2
salivary glue protein Sgs-3-like, transcript variant X3
salivary glue protein Sgs-3-like, transcript variant X1
salivary glue protein Sgs-3-like, transcript variant X2
salivary glue protein Sgs-3-like isoform X1
salivary glue protein Sgs-3-like isoform X2
salivary glue protein Sgs-3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316435, transcript variant X2
uncharacterized LOC124316435, transcript variant X1
retinol-binding protein pinta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
retinol-binding protein pinta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
retinol-binding protein pinta-like isoform X1
retinol-binding protein pinta-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
retinol-binding protein pinta-like, transcript variant X3
retinol-binding protein pinta-like isoform X2
uncharacterized LOC124316426, transcript variant X1
uncharacterized LOC124316426, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124316494, transcript variant X1
uncharacterized LOC124316494, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized protein LOC124316494 isoform X2
uncharacterized protein LOC124316494 isoform X1
cell cycle control protein 50A-like, transcript variant X2
cell cycle control protein 50A-like, transcript variant X3
cell cycle control protein 50A-like, transcript variant X1
cell cycle control protein 50A-like, transcript variant X4
cell cycle control protein 50A-like isoform X2
cell cycle control protein 50A-like isoform X3
cell cycle control protein 50A-like isoform X1
cell cycle control protein 50A-like isoform X4
probable methyltransferase-like protein 24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC124316160, transcript variant X1
uncharacterized LOC124316160, transcript variant X3
uncharacterized LOC124316160, transcript variant X2
uncharacterized protein LOC124316160 isoform X3
uncharacterized protein LOC124316160 isoform X2
uncharacterized protein LOC124316160 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124316532, transcript variant X1
uncharacterized LOC124316532, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC124316532 isoform X2
uncharacterized protein LOC124316532 isoform X1
RNA-binding protein Musashi homolog 2-like, transcript variant X3
RNA-binding protein Musashi homolog 2-like, transcript variant X2
RNA-binding protein Musashi homolog 2-like, transcript variant X1
RNA-binding protein Musashi homolog 2-like, transcript variant X5
RNA-binding protein Musashi homolog 2-like, transcript variant X4
RNA-binding protein Musashi homolog 2-like isoform X1
RNA-binding protein Musashi homolog 2-like isoform X3
RNA-binding protein Musashi homolog 2-like isoform X2
rab5 GDP/GTP exchange factor-like, transcript variant X3
rab5 GDP/GTP exchange factor-like, transcript variant X2
rab5 GDP/GTP exchange factor-like, transcript variant X1
fibroblast growth factor receptor 2-like, transcript variant X4
fibroblast growth factor receptor 2-like, transcript variant X1
fibroblast growth factor receptor 2-like, transcript variant X2
fibroblast growth factor receptor 2-like, transcript variant X3
fibroblast growth factor receptor 2-like isoform X2
galactosylceramide sulfotransferase-like, transcript variant X1
galactosylceramide sulfotransferase-like, transcript variant X3
galactosylceramide sulfotransferase-like, transcript variant X2
galactosylceramide sulfotransferase-like, transcript variant X4
galactosylceramide sulfotransferase-like isoform X1
galactosylceramide sulfotransferase-like isoform X2
galactosylceramide sulfotransferase-like isoform X3
uncharacterized LOC124316646, transcript variant X1
uncharacterized LOC124316646, transcript variant X2
uncharacterized LOC124316646, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B-like
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X3
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X1
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X2
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X4
uncharacterized protein LOC124316391 isoform X2
uncharacterized protein LOC124316391 isoform X1
N-acetylneuraminate 9-O-acetyltransferase-like isoform X3
N-acetylneuraminate 9-O-acetyltransferase-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X3
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X4
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X2
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X1
phytanoyl-CoA dioxygenase, peroxisomal-like
putative inhibitor of apoptosis, transcript variant X2
putative inhibitor of apoptosis, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
collagenase 3-like, transcript variant X7
collagenase 3-like, transcript variant X4
collagenase 3-like, transcript variant X5
collagenase 3-like, transcript variant X3
collagenase 3-like, transcript variant X1
collagenase 3-like, transcript variant X2
collagenase 3-like, transcript variant X8
collagenase 3-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC124316241 isoform X3
uncharacterized protein LOC124316241 isoform X4
uncharacterized protein LOC124316241 isoform X2
uncharacterized protein LOC124316241 isoform X1
collagenase 3-like, transcript variant X10
matrix metalloproteinase-A-like isoform X6
collagenase 3-like, transcript variant X6
matrix metalloproteinase-A-like isoform X5
uncharacterized protein LOC124316241 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316640, transcript variant X1
uncharacterized LOC124316640, transcript variant X2
uncharacterized LOC124316617, transcript variant X1
uncharacterized LOC124316617, transcript variant X3
uncharacterized LOC124316617, transcript variant X4
uncharacterized LOC124316617, transcript variant X5
uncharacterized LOC124316617, transcript variant X2
spermine synthase-like, transcript variant X2
spermine synthase-like, transcript variant X1
speckle-type POZ protein B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
speckle-type POZ protein B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
speckle-type POZ protein B-like isoform X2
speckle-type POZ protein B-like, transcript variant X1
speckle-type POZ protein B-like isoform X1
glutamate synthase [NADH]-like, transcript variant X1
glutamate synthase [NADH]-like, transcript variant X2
replication stress response regulator SDE2-like
uncharacterized LOC124316625, transcript variant X2
uncharacterized LOC124316625, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
protein tramtrack, beta isoform-like, transcript variant X2
protein tramtrack, beta isoform-like, transcript variant X3
protein tramtrack, beta isoform-like, transcript variant X5
protein tramtrack, beta isoform-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein tramtrack, beta isoform-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein tramtrack, beta isoform-like, transcript variant X1
protein tramtrack, beta isoform-like, transcript variant X4
protein tramtrack, beta isoform-like isoform X4
protein tramtrack, beta isoform-like isoform X1
protein tramtrack, beta isoform-like isoform X7
protein tramtrack, beta isoform-like isoform X2
protein tramtrack, beta isoform-like isoform X3
protein tramtrack, beta isoform-like isoform X5
protein tramtrack, beta isoform-like isoform X6
TD and POZ domain-containing protein 1-like isoform X1
uncharacterized LOC124316349, transcript variant X2
uncharacterized LOC124316349, transcript variant X1
uncharacterized protein LOC124316349 isoform X2
uncharacterized protein LOC124316349 isoform X1
uncharacterized LOC124316153, transcript variant X2
uncharacterized LOC124316246, transcript variant X1
uncharacterized LOC124316246, transcript variant X2
uncharacterized LOC124316246, transcript variant X3
uncharacterized protein LOC124316246 isoform X1
uncharacterized protein LOC124316246 isoform X2
uncharacterized LOC124316287, transcript variant X2
uncharacterized LOC124316287, transcript variant X1
uncharacterized protein LOC124316287 isoform X1
uncharacterized protein LOC124316287 isoform X2
uncharacterized LOC124316153, transcript variant X3
uncharacterized LOC124316153, transcript variant X1
uncharacterized protein LOC124316153 isoform X2
uncharacterized protein LOC124316153 isoform X1
uncharacterized LOC124316225, transcript variant X2
uncharacterized LOC124316225, transcript variant X1
uncharacterized protein LOC124316225 isoform X2
uncharacterized protein LOC124316225 isoform X1
uncharacterized LOC124316223, transcript variant X2
uncharacterized LOC124316223, transcript variant X1
uncharacterized protein LOC124316223 isoform X2
uncharacterized protein LOC124316223 isoform X1
uncharacterized LOC124316223, transcript variant X3
uncharacterized protein LOC124316223 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC124316235, transcript variant X2
uncharacterized LOC124316235, transcript variant X1
uncharacterized protein LOC124316235 isoform X2
uncharacterized protein LOC124316235 isoform X1
uncharacterized LOC124316574, transcript variant X2
uncharacterized LOC124316574, transcript variant X3
uncharacterized LOC124316574, transcript variant X4
uncharacterized LOC124316399, transcript variant X2
uncharacterized LOC124316399, transcript variant X1
uncharacterized LOC124316574, transcript variant X1
uncharacterized LOC124316574, transcript variant X5
uncharacterized LOC124316632, transcript variant X2
uncharacterized LOC124316632, transcript variant X1
uncharacterized LOC124316522, transcript variant X2
uncharacterized LOC124316522, transcript variant X1
uncharacterized LOC124316514, transcript variant X2
uncharacterized LOC124316514, transcript variant X1
uncharacterized protein LOC124316514 isoform X2
uncharacterized protein LOC124316514 isoform X1
uncharacterized LOC124316410, transcript variant X2
uncharacterized LOC124316410, transcript variant X1
uncharacterized protein LOC124316410 isoform X2
uncharacterized protein LOC124316410 isoform X1
TD and POZ domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carbohydrate sulfotransferase 7-like, transcript variant X6
carbohydrate sulfotransferase 7-like, transcript variant X8
carbohydrate sulfotransferase 7-like, transcript variant X7
carbohydrate sulfotransferase 7-like, transcript variant X9
carbohydrate sulfotransferase 7-like, transcript variant X5
carbohydrate sulfotransferase 7-like, transcript variant X1
carbohydrate sulfotransferase 7-like, transcript variant X4
carbohydrate sulfotransferase 7-like, transcript variant X3
carbohydrate sulfotransferase 7-like, transcript variant X2
carbohydrate sulfotransferase 7-like isoform X1
carbohydrate sulfotransferase 7-like isoform X3
carbohydrate sulfotransferase 7-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124316620, transcript variant X3
uncharacterized LOC124316620, transcript variant X2
uncharacterized LOC124316620, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124316185, transcript variant X1
uncharacterized protein LOC124316185 isoform X1
uncharacterized LOC124316185, transcript variant X2
uncharacterized protein LOC124316185 isoform X2
uncharacterized LOC124316260, transcript variant X1
uncharacterized LOC124316260, transcript variant X2
uncharacterized protein LOC124316260 isoform X1
uncharacterized protein LOC124316260 isoform X2
uncharacterized LOC124316262, transcript variant X4
uncharacterized LOC124316262, transcript variant X3
uncharacterized LOC124316262, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC124316262 isoform X3
uncharacterized protein LOC124316262 isoform X1
uncharacterized protein LOC124316262 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124316155 isoform X3
uncharacterized protein LOC124316155 isoform X2
kunitz-type serine protease inhibitor nigrescinin-6-like, transcript variant X1
kunitz-type serine protease inhibitor nigrescinin-6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
tissue factor pathway inhibitor-like isoform X1
kunitz-type serine protease inhibitor nigrescinin-6-like isoform X2
uncharacterized LOC124316262, transcript variant X2
uncharacterized protein LOC124316262 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124316633, transcript variant X3
uncharacterized LOC124316633, transcript variant X2
uncharacterized LOC124316633, transcript variant X1
uncharacterized LOC124316633, transcript variant X4
uncharacterized LOC124316345, transcript variant X4
uncharacterized LOC124316345, transcript variant X3
uncharacterized LOC124316345, transcript variant X2
uncharacterized LOC124316345, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC124316340, transcript variant X2
uncharacterized LOC124316340, transcript variant X1
uncharacterized protein LOC124316340 isoform X2
uncharacterized protein LOC124316340 isoform X1
uncharacterized LOC124316297, transcript variant X1
uncharacterized LOC124316297, transcript variant X2
uncharacterized protein LOC124316297 isoform X1
uncharacterized protein LOC124316297 isoform X2
uncharacterized LOC124316230, transcript variant X2
uncharacterized LOC124316230, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124316641, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124316641, transcript variant X1
uncharacterized LOC124316270, transcript variant X3
uncharacterized LOC124316270, transcript variant X1
uncharacterized LOC124316270, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124316198, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316198, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124316198 isoform X1
uncharacterized protein LOC124316198 isoform X2
uncharacterized LOC124316568, transcript variant X1
uncharacterized LOC124316568, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized protein LOC124316568 isoform X1
uncharacterized protein LOC124316568 isoform X2
uncharacterized LOC124316215, transcript variant X2
uncharacterized LOC124316215, transcript variant X1
gastric triacylglycerol lipase-like, transcript variant X3
gastric triacylglycerol lipase-like, transcript variant X2
gastric triacylglycerol lipase-like, transcript variant X1
gastric triacylglycerol lipase-like isoform X1
gastric triacylglycerol lipase-like isoform X3
gastric triacylglycerol lipase-like isoform X2
uncharacterized LOC124316205, transcript variant X1
uncharacterized LOC124316205, transcript variant X2
uncharacterized protein LOC124316205 isoform X2
uncharacterized protein LOC124316205 isoform X1
uncharacterized LOC124316144, transcript variant X2
uncharacterized LOC124316144, transcript variant X1
uncharacterized protein LOC124316144 isoform X2
uncharacterized protein LOC124316144 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC124316156 isoform X2
oxidized purine nucleoside triphosphate hydrolase-like, transcript variant X2
oxidized purine nucleoside triphosphate hydrolase-like, transcript variant X1
oxidized purine nucleoside triphosphate hydrolase-like, transcript variant X3
oxidized purine nucleoside triphosphate hydrolase-like, transcript variant X4
oxidized purine nucleoside triphosphate hydrolase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC124316278, transcript variant X4
uncharacterized LOC124316278, transcript variant X5
uncharacterized LOC124316278, transcript variant X2
uncharacterized LOC124316278, transcript variant X1
uncharacterized LOC124316278, transcript variant X6
uncharacterized LOC124316278, transcript variant X3
uncharacterized LOC124316668, transcript variant X2
uncharacterized LOC124316668, transcript variant X1
serine--tRNA ligase, cytoplasmic-like, transcript variant X1
serine--tRNA ligase, cytoplasmic-like, transcript variant X2
serine--tRNA ligase, cytoplasmic-like isoform X2
serine--tRNA ligase, cytoplasmic-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124316232, transcript variant X1
uncharacterized LOC124316232, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC124316233, transcript variant X2
uncharacterized protein LOC124316233 isoform X2
uncharacterized LOC124316233, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized protein LOC124316233 isoform X1
uncharacterized LOC124316222, transcript variant X2
uncharacterized LOC124316222, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
N-acetylneuraminate 9-O-acetyltransferase-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X2
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X1
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X1
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X3
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X2
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X4
tRNA (guanine(10)-N2)-methyltransferase homolog, transcript variant X5
tRNA (guanine(10)-N2)-methyltransferase homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316545, transcript variant X4
uncharacterized LOC124316545, transcript variant X3
uncharacterized LOC124316545, transcript variant X2
uncharacterized LOC124316545, transcript variant X1
uncharacterized protein LOC124316545 isoform X2
uncharacterized protein LOC124316545 isoform X1
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC124316131, transcript variant X2
uncharacterized LOC124316131, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transcription initiation factor TFIID subunit 5-like
mitogen-activated protein kinase HOG1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124316124, transcript variant X2
uncharacterized LOC124316124, transcript variant X1
uncharacterized LOC124316124, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
glucose-6-phosphate isomerase-like, transcript variant X2
glucose-6-phosphate isomerase-like isoform X2
glucose-6-phosphate isomerase-like, transcript variant X1
glucose-6-phosphate isomerase-like isoform X1
vascular endothelial growth factor receptor kdr-like, transcript variant X3
vascular endothelial growth factor receptor kdr-like, transcript variant X1
vascular endothelial growth factor receptor kdr-like, transcript variant X2
vascular endothelial growth factor receptor kdr-like isoform X1
vascular endothelial growth factor receptor kdr-like isoform X2
vascular endothelial growth factor receptor kdr-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins
uncharacterized LOC124316347, transcript variant X3
uncharacterized LOC124316347, transcript variant X4
uncharacterized LOC124316347, transcript variant X2
uncharacterized LOC124316347, transcript variant X1
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X5
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X6
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X3
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X1
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X2
glucose-6-phosphate 1-dehydrogenase-like, transcript variant X4
glucose-6-phosphate 1-dehydrogenase-like isoform X1
glucose-6-phosphate 1-dehydrogenase-like isoform X2
glucose-6-phosphate 1-dehydrogenase-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124316145, transcript variant X2
uncharacterized LOC124316145, transcript variant X1
uncharacterized LOC124316145, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124316145 isoform X1
uncharacterized protein LOC124316145 isoform X2
protein strawberry notch-like, transcript variant X2
protein strawberry notch-like, transcript variant X1
protein strawberry notch-like isoform X2
protein strawberry notch-like isoform X1
glutamate receptor ionotropic, kainate glr-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glycine-rich cell wall structural protein-like
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial-like, transcript variant X2
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial-like, transcript variant X1
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial-like
3-hydroxyisobutyrate dehydrogenase, mitochondrial-like
uncharacterized LOC124316254, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124316254, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124316254 isoform X1
uncharacterized protein LOC124316254 isoform X2
glucose-6-phosphatase catalytic subunit 1-like
uncharacterized LOC124316130, transcript variant X2
uncharacterized LOC124316130, transcript variant X1
uncharacterized protein LOC124316130 isoform X1
uncharacterized protein LOC124316130 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124316496, transcript variant X2
uncharacterized LOC124316496, transcript variant X3
uncharacterized LOC124316496, transcript variant X4
uncharacterized LOC124316496, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124316496 isoform X1
uncharacterized protein LOC124316496 isoform X2
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like, transcript variant X1
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like, transcript variant X2
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like
putative zinc finger protein 833, transcript variant X1
putative zinc finger protein 833, transcript variant X2
putative zinc finger protein 833 isoform X2
PHD finger protein 20-like, transcript variant X2
PHD finger protein 20-like, transcript variant X1
BRCA2-interacting transcriptional repressor EMSY-like
myotubularin-related protein 2-like, transcript variant X2
myotubularin-related protein 2-like, transcript variant X1
myotubularin-related protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
chymotrypsin BI-like, transcript variant X1
chymotrypsin BI-like, transcript variant X2
DNA repair protein RAD51 homolog A-like, transcript variant X3
DNA repair protein RAD51 homolog A-like, transcript variant X2
DNA repair protein RAD51 homolog A-like, transcript variant X1
protein maelstrom homolog, transcript variant X1
protein maelstrom homolog, transcript variant X4
protein maelstrom homolog, transcript variant X3
protein maelstrom homolog, transcript variant X2
histone-lysine N-methyltransferase 2D-like, transcript variant X2
histone-lysine N-methyltransferase 2D-like, transcript variant X1
histone-lysine N-methyltransferase 2D-like, transcript variant X3
histone-lysine N-methyltransferase 2D-like, transcript variant X4
histone-lysine N-methyltransferase 2D-like isoform X1
uncharacterized protein LOC124316119 isoform X3
histone-lysine N-methyltransferase 2D-like isoform X2
uncharacterized LOC124316485, transcript variant X1
uncharacterized LOC124316485, transcript variant X2
uncharacterized LOC124316256, transcript variant X1
uncharacterized LOC124316256, transcript variant X3
uncharacterized LOC124316256, transcript variant X2
uncharacterized LOC124316637, transcript variant X2
uncharacterized LOC124316637, transcript variant X3
uncharacterized LOC124316637, transcript variant X5
uncharacterized LOC124316637, transcript variant X4
uncharacterized LOC124316637, transcript variant X1
calcium uniporter protein, mitochondrial-like
uncharacterized LOC124316133, transcript variant X1
uncharacterized LOC124316133, transcript variant X2
uncharacterized protein LOC124316133 isoform X1
uncharacterized protein LOC124316133 isoform X2
uncharacterized LOC124316643, transcript variant X2
uncharacterized LOC124316643, transcript variant X1
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X1
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X2
zinc finger Ran-binding domain-containing protein 2-like isoform X2
zinc finger Ran-binding domain-containing protein 2-like isoform X1
translocon-associated protein subunit delta-like
serine/threonine-protein kinase PLK1-like
ERI1 exoribonuclease 3-like, transcript variant X2
ERI1 exoribonuclease 3-like, transcript variant X1
uncharacterized LOC124316548, transcript variant X1
uncharacterized LOC124316548, transcript variant X2
uncharacterized LOC124316548, transcript variant X5
uncharacterized LOC124316548, transcript variant X6
uncharacterized LOC124316548, transcript variant X3
uncharacterized LOC124316548, transcript variant X4
uncharacterized protein LOC124316548 isoform X1
uncharacterized protein LOC124316548 isoform X2
uncharacterized protein LOC124316548 isoform X3
uncharacterized protein LOC124316548 isoform X4
uncharacterized protein LOC124316548 isoform X5
zinc finger BED domain-containing protein RICESLEEPER 2-like, transcript variant X2
zinc finger BED domain-containing protein RICESLEEPER 2-like, transcript variant X1
zinc finger BED domain-containing protein RICESLEEPER 2-like isoform X2
zinc finger BED domain-containing protein RICESLEEPER 2-like isoform X1
ubiquitin-like modifier-activating enzyme ATG7
transcription cofactor vestigial-like protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
transcription cofactor vestigial-like protein 4, transcript variant X1
transcription cofactor vestigial-like protein 4 isoform X2
uncharacterized protein PB18E9.04c-like isoform X1
5'-nucleotidase domain-containing protein 1-like
coiled-coil domain-containing protein 103-like, transcript variant X2
coiled-coil domain-containing protein 103-like, transcript variant X1
coiled-coil domain-containing protein 103-like
eukaryotic translation initiation factor eIF1
uncharacterized LOC124316612, transcript variant X1
uncharacterized LOC124316612, transcript variant X2
LIM and senescent cell antigen-like-containing domain protein 1, transcript variant X2
LIM and senescent cell antigen-like-containing domain protein 1, transcript variant X4
LIM and senescent cell antigen-like-containing domain protein 1, transcript variant X3
LIM and senescent cell antigen-like-containing domain protein 1, transcript variant X1
LIM and senescent cell antigen-like-containing domain protein 1 isoform X2
LIM and senescent cell antigen-like-containing domain protein 1 isoform X3
LIM and senescent cell antigen-like-containing domain protein 1 isoform X1
LIM and senescent cell antigen-like-containing domain protein 1 isoform X4
protein SAND-like, transcript variant X1
protein SAND-like, transcript variant X2
phosphatidylinositol-3-phosphatase SAC1-like
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
uncharacterized protein C18orf19 homolog A-like
mediator of RNA polymerase II transcription subunit 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vacuolar protein sorting-associated protein 33A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
stromal membrane-associated protein 1-like
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
cell cycle checkpoint control protein RAD9A-like, transcript variant X1
cell cycle checkpoint control protein RAD9A-like, transcript variant X2
cell cycle checkpoint control protein RAD9A-like isoform X1
cell cycle checkpoint control protein RAD9A-like isoform X2
squamous cell carcinoma antigen recognized by T-cells 3-like
uncharacterized LOC124316121, transcript variant X1
uncharacterized LOC124316121, transcript variant X2
uncharacterized LOC124316121, transcript variant X3
uncharacterized protein LOC124316121 isoform X1
uncharacterized protein LOC124316121 isoform X2
uncharacterized protein LOC124316121 isoform X3
longitudinals lacking protein, isoforms H/M/V-like, transcript variant X3
longitudinals lacking protein, isoforms H/M/V-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
longitudinals lacking protein, isoforms H/M/V-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
longitudinals lacking protein, isoforms H/M/V-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
longitudinals lacking protein, isoforms H/M/V-like isoform X3
protein tramtrack, beta isoform-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
protein tramtrack, beta isoform-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein tramtrack, beta isoform-like isoform X8
protein tramtrack, beta isoform-like isoform X9
uncharacterized LOC124316169, transcript variant X5
uncharacterized LOC124316169, transcript variant X6
uncharacterized LOC124316169, transcript variant X7
uncharacterized LOC124316169, transcript variant X1
uncharacterized LOC124316169, transcript variant X2
uncharacterized LOC124316169, transcript variant X3
uncharacterized protein LOC124316169 isoform X1
uncharacterized protein LOC124316169 isoform X2
uncharacterized protein LOC124316169 isoform X3
uncharacterized protein LOC124316169 isoform X5
uncharacterized protein LOC124316169 isoform X6
uncharacterized LOC124316169, transcript variant X4
uncharacterized protein LOC124316169 isoform X4
uncharacterized LOC124316169, transcript variant X8
uncharacterized protein LOC124316169 isoform X7
urokinase-type plasminogen activator-like
myotubularin-related protein 8-like, transcript variant X3
myotubularin-related protein 8-like isoform X2
myotubularin-related protein 8-like, transcript variant X1
myotubularin-related protein 8-like, transcript variant X2
myotubularin-related protein 8-like isoform X1
uncharacterized LOC124316670, transcript variant X1
uncharacterized LOC124316670, transcript variant X3
uncharacterized LOC124316670, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 2-like
calcium uniporter protein, mitochondrial-like, transcript variant X1
calcium uniporter protein, mitochondrial-like, transcript variant X2
calcium uniporter protein, mitochondrial-like isoform X1
calcium uniporter protein, mitochondrial-like isoform X2
flocculation protein FLO11-like, transcript variant X3
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like isoform X2
flocculation protein FLO11-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
triokinase/FMN cyclase-like, transcript variant X2
triokinase/FMN cyclase-like, transcript variant X1
extended synaptotagmin-2-like, transcript variant X1
extended synaptotagmin-2-like, transcript variant X3
extended synaptotagmin-2-like, transcript variant X2
extended synaptotagmin-2-like, transcript variant X4
extended synaptotagmin-2-like isoform X1
extended synaptotagmin-2-like isoform X2
extended synaptotagmin-2-like isoform X3
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cell wall protein DAN4-like, transcript variant X2
cell wall protein DAN4-like, transcript variant X1
cell wall integrity and stress response component 4-like isoform X1
protein lap4-like, transcript variant X2
protein lap4-like, transcript variant X1
RNA polymerase I-specific transcription initiation factor RRN3-like
paternally-expressed gene 3 protein-like, transcript variant X2
paternally-expressed gene 3 protein-like, transcript variant X3
paternally-expressed gene 3 protein-like, transcript variant X1
paternally-expressed gene 3 protein-like isoform X2
paternally-expressed gene 3 protein-like isoform X3
paternally-expressed gene 3 protein-like isoform X1
diacylglycerol kinase delta-like, transcript variant X1
diacylglycerol kinase delta-like, transcript variant X2
diacylglycerol kinase delta-like, transcript variant X3
diacylglycerol kinase delta-like, transcript variant X7
diacylglycerol kinase delta-like isoform X1
diacylglycerol kinase delta-like isoform X3
diacylglycerol kinase delta-like isoform X5
diacylglycerol kinase delta-like isoform X2
diacylglycerol kinase delta-like, transcript variant X5
diacylglycerol kinase delta-like, transcript variant X6
diacylglycerol kinase delta-like, transcript variant X4
diacylglycerol kinase delta-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
NEDD8 ultimate buster 1-like, transcript variant X2
NEDD8 ultimate buster 1-like, transcript variant X4
NEDD8 ultimate buster 1-like, transcript variant X1
NEDD8 ultimate buster 1-like, transcript variant X5
NEDD8 ultimate buster 1-like, transcript variant X3